Today, I review, link to, and embed Dr. Brad Stanfield‘s “The Cholesterol War Is Over (Here’s Who Won)”.
All that follows is from the above resource.
The Cholesterol War Is Over (Here’s Who Won)Apr 16, 2026🩺 Get your personalized health plan: https://drstanfield.com/pages/roadmap ✔️ X: https://x.com/BradStanfieldMD✔️ Patreon:/ bradstanfieldmd
Timestamps: 00:00 The Dallas Heart Study and PCSK902:58 The Fourier Trial03:34 The VESALIUS-CV Trial08:21 The Case for Lower LDL Targets08:26 The Ez-PAVE Study10:13 The PESA Study11:53 The Underutilization of Ezetimibe13:22 Conclusion and Future DirectionsHere are the links to the research papers referenced in the video: 1. doi: 10.1001/jama.2026.3277 https://jamanetwork.com/journals/jama… VESALIUS-CV Diabetes Subgroup Analysis — JAMA 20262. doi: 10.1172/JCI84086 https://pmc.ncbi.nlm.nih.gov/articles… JCI Conversation with Helen Hobbs — 20153. doi: 10.1056/NEJMoa054013 https://www.nejm.org/doi/full/10.1056… Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease — NEJM 20064. doi: 10.3389/fcvm.2021.764038 https://pmc.ncbi.nlm.nih.gov/articles… Regulation of PCSK9 Expression and Function: Mechanisms and Therapeutic Implications — Frontiers in Cardiovascular Medicine 20215. doi: 10.1016/j.jacc.2012.08.986 https://www.jacc.org/doi/10.1016/j.ja… Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels — JACC 20126. doi: 10.1056/NEJMoa1615664 https://www.nejm.org/doi/full/10.1056… Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease (FOURIER) — NEJM 20177. doi: 10.1056/NEJMoa2514428 https://www.nejm.org/doi/full/10.1056… Evolocumab in Patients without a Previous Myocardial Infarction or Stroke (VESALIUS-CV) — NEJM 20258. https://www.acc.org/About-ACC/Press-R… Evolocumab Cuts Cardiac Risk in Patients Without Known Atherosclerosis and With Diabetes — ACC Press Release, March 20269. https://www.peoplespharmacy.com/artic… Woman Has Heart Attack Despite Very Low Cholesterol — People’s Pharmacy10. doi: 10.1016/j.ahj.2008.08.010 https://pubmed.ncbi.nlm.nih.gov/19081… Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines — American Heart Journal 200911. doi: 10.1056/NEJMoa2600283 https://www.nejm.org/doi/full/10.1056… Ez-PAVE Trial — NEJM 202612. https://www.tctmd.com/news/very-low-l… Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE — TCTMD (Cannon + Aspry quotes)13. doi: 10.1016/j.jacc.2017.10.024 https://www.jacc.org/doi/10.1016/j.ja… Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors (PESA) — JACC 201714. doi: 10.1177/11772719241257410 https://pmc.ncbi.nlm.nih.gov/articles… Are We Using Ezetimibe As Much As We Should? — Therapeutic Advances in Cardiovascular Disease 202415. doi: 10.1001/jama.2025.20620 https://jamanetwork.com/journals/jama… Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia — JAMA 202516. https://www.utsouthwestern.edu/newsro… Updated cholesterol guideline shifts focus to earlier prevention — UT Southwestern Newsroom, March 2026 (Rohatgi quote)17. doi: 10.1016/j.jacc.2012.09.017 https://www.jacc.org/doi/10.1016/j.ja… Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease — JACC 2012Thumbnail by James KellyVideo edited by Troy Young Script by John Milliken The content contained in this video, and its accompanying description, is not intended to replace viewers’ relationships with their own medical practitioner. Always speak with your doctor regarding the content of this channel, and especially before using any products, services, or devices discussed on this channel.
